Splenosis Mimicking Peritoneal Carcinomatosis

Teaching point: Splenosis must be considered in patients with history of splenectomy or splenic trauma, later presenting with multiple peritoneal nodules. Published on 2020-04-06 10:38:55
Source: Journal of the Belgian Society of Radiology - Category: Radiology Source Type: research

Related Links:

Management of malignant gastrointestinal obstruction (MGIO) is more challenging in presence of peritoneal carcinomatosis (PC). Outcome data to guide the management of MGIO with PC is lacking. We aimed to comparethe clinical outcomes and adverse events between endoscopic and surgical palliation and identify predictors of stent success in patients with MGIO with PC.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Poster abstracts Source Type: research
Malignant gastrointestinal obstruction (MGIO) is an alarming complication in patients with peritoneal carcinomatosis (PC). Palliative surgery and enteral stenting offer symptomatic relief but recurrence can occur. We aimed to investigate the treatment outcomes in the recurrent MGIO cases managed surgically or endoscopically and identify predictors of success in endoscopic management.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Poster abstracts Source Type: research
Gastric outlet obstruction (GOO) is frequently associated with peritoneal carcinomatosis. Palliative surgical gastrojejunostomy (SGJ) may be performed in these patients when conservative treatment fails, however is associated with substantial post-operative morbidity. Endoscopic ultrasound guided gastroenterostomy (EUS-GE) using lumen apposing metal stents (LAMS) has recently emerged as a less invasive modality for the treatment of GOO, however, data comparing these treatment options in patients with peritoneal carcinomatosis is limited.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Poster abstracts Source Type: research
This study determines how much cytoreduction for small bowel neuroendocrine tumors with peritoneal carcinomatosis and liver metastases can be achieved and the corresponding survival benefits of different levels of clearance.
Source: Surgery - Category: Surgery Authors: Source Type: research
Conclusions: Serum lactate is a risk factor for postoperative complications in patients undergoing cytoreduction surgery in peritoneal carcinomatosis. PMID: 32434292 [PubMed - as supplied by publisher]
Source: Korean Journal of Anesthesiology - Category: Anesthesiology Tags: Korean J Anesthesiol Source Type: research
ng Yang Jen-Ruei Chen Debulking surgery followed by systemic chemotherapy—including three-weekly intravenous paclitaxel and carboplatin (GOG-158)—is the cornerstone for advanced epithelial ovarian, fallopian tubal, and peritoneal cancer (EOC) treatment. In this scenario, Federation of Gynecology and Obstetrics (FIGO) stage, cell types, completeness of surgery, lymph nodes (LN) status, adjuvant chemotherapy regimens, survival status, progression-free survival (PFS), and overall survival (OS) of 192 patients diagnosed as having stage IIIA1–IVB EOC over January 2008–December 2017 ...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
We report a case of diffuse peritoneal aspergillosis. A 56-year old female with a history of recent renal transplantation was admitted with a suspicion of peritoneal carcinomatosis following a native computed tomography scan. Gray scale abdominal ultrasound showed multiple peritoneal masses. Upon performing contrast-enhanced ultrasound these masses demonstrated peripheral arterial enhancement and slow wash-out during the venous phase. The final histopathological examination confirmed a diagnosis of peritoneal aspergillosis. Gray scale ultrasonography in combination with contrast-enhanced ultrasonography is useful in the ev...
Source: Medical Ultrasonography - Category: Radiology Tags: Med Ultrason Source Type: research
Conditions:   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma Interventions:   Drug: Carboplatin;   Biological: Pembrolizumab Sponsors:   University of Washington;   National Cancer Institute (NCI);   United States Department of Defense Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
AbstractObjectivesTo investigate the predictive value of peritoneal carcinomatosis (PC) quantification by DWI in determining incomplete tumour debulking in ovarian carcinoma (OC).MethodsProspective patients with suspected stage III –IV or recurrent OC were recruited for DWI before surgery. PC on DWI was segmented semi-automatically byk-means clustering, retaining voxels with intermediate apparent diffusion coefficient (ADC) to quantify PC burden. A scoring system, functional peritoneal cancer index (fPCI), was proposed based on the segmentation of tumour volume in 13 abdominopelvic regions with additional point given...
Source: European Radiology - Category: Radiology Source Type: research
Conclusions: The patients demonstrated action competence in relation to their preoperative preparation. However, in relation to the kind of prehabilitation that required lifestyle changes, their action competence needed to be developed and supported. To do so, it is necessary to ask questions that cover the patients' perspectives of the what, when, where, who, and why of prehabilitation.IMPLICATIONS FOR REHABILITATIONPatients undergoing major, abdominal cancer surgery have very clear opinions about what are important to them during the preoperative period, and this is not only limited to prehabilitation-related actions.In ...
Source: Disability and Rehabilitation - Category: Rehabilitation Authors: Tags: Disabil Rehabil Source Type: research
More News: Belgium Health | Cancer & Oncology | Carcinoma | Peritoneal Cancer | Radiology | Splenectomy | Teaching | Universities & Medical Training